We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The test uses a drop of blood to detect COVID-19 antibodies in approximately 10 minutes. It can detect both the presence of the virus and a patient’s potential antibody immunity to it. Read More
“Right now, we have no evidence that the use of a serologic test can show that an individual is immune or protected from reinfection,” the WHO official said. Read More
The FDA issued a final rule banning electrical stimulation devices (ESDs) used to reduce aggressive or self-harming behavior, saying that better treatment options are now available. Read More
Under a settlement with the Federal Trade Commission, devicemaker NeuroMetrix agreed to pay at least $4 million and stop making deceptive claims that its Quell transcutaneous electrical nerve stimulation device treats pain throughout the body when placed below the knee. Read More
The FDA announced in a new guidance that it does not plan to object to delays in adverse event reporting for medical products during the pandemic. Read More
The FDA issued a new policy that allows the use of validated COVID-19 diagnostics while the agency reviews Emergency Use Authorization (EUA) requests. Read More
The EU’s Medical Device Coordination Group released a guidance for devicemakers on transitional provisions for Class I devices under the Medical Device Regulation (MDR). Read More